Propan-1-aminium chloride
Names
[ CAS No. ]:
556-53-6
[ Name ]:
Propan-1-aminium chloride
[Synonym ]:
1-Propanamine, hydrochloride (1:1)
MFCD00012911
1-Propanamine hydrochloride (1:1)
Propan-1-aminium chloride
Propan-1-amine hydrochloride (1:1)
EINECS 209-129-9
1-Propanamine hydrochloride
propan-1-amine,hydrochloride
Chemical & Physical Properties
[ Boiling Point ]:
46.9ºC at 760 mmHg
[ Melting Point ]:
160-162 °C(lit.)
[ Molecular Formula ]:
C3H10ClN
[ Molecular Weight ]:
95.571
[ Exact Mass ]:
95.050179
[ PSA ]:
26.02000
[ LogP ]:
1.85740
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- UI3057000
- CHEMICAL NAME :
- Propylamine, hydrochloride
- CAS REGISTRY NUMBER :
- 556-53-6
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C3-H9-N.Cl-H
- MOLECULAR WEIGHT :
- 95.59
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1545 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- Volume(issue)/page/year: 97,1117,1977
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302-H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xn: Harmful;
[ Risk Phrases ]:
R22
[ Safety Phrases ]:
S26-S36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
UI3057000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
J. Chromatogr. A. 325(2) , 395-411, (1985)
This paper deals with the specific identification of several thiazide, potassium-sparing and loop diuretics. The liquid chromatographic behaviour of these compounds is studied. Different organic modif...
Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.Neuropsychopharmacology 39(8) , 1996-2007, (2014)
Drug interaction between inhibitors of monoamine oxidase (MAOIs) and selective serotonin (5-hydroxytryptamine, 5-HT) reuptake (SSRIs) induces serotonin syndrome, which is usually mild but occasionally...